Oxytocin vs Vasopressin

How they differ

Each row below repeats what the two profiles cite. It is not a ranking or a recommendation.

Side by side

TopicOxytocinVasopressin
What it is

A synthetic version of oxytocin, a nine-amino-acid hormone found in the pituitary gland, according to the Pitocin label.1

A synthetic polypeptide hormone, arginine vasopressin, that acts on V1 receptors in blood vessels and V2 receptors in the kidney, according to the label.3

FDA status

FDA-approved

FDA-approved as Pitocin for labor and bleeding after birth1,2

FDA-approved. Drugs@FDA lists Pitocin, NDA 018261, with an original approval date of November 19, 1980. The label’s boxed warning states that it is not indicated for elective induction of labor.1,2

Is oxytocin FDA-approved?

FDA-approved

FDA-approved as Vasostrict for vasodilatory shock3,4

FDA-approved. Drugs@FDA lists Vasostrict with an original approval date of April 17, 2014. The cited label has no boxed warning.3,4

Is vasopressin FDA-approved?

HHS compounding policy, October 30, 2026

Not among the six peptides the policy lists.5

HHS’s October 30, 2026 draft enforcement-discretion policy lists six peptides in its Appendix A: BPC-157, Epitalon, KPV, MOTS-c, Semax and TB-500. Oxytocin is not among them.5,6

Not among the six peptides the policy lists.5

FDA compounding safety-risk page

Not addressed in this profile’s sources.

Not addressed in this profile’s sources.

Kinds of studies cited

Large randomized human trials

  • Large randomized human trial CHAMPION: a randomized, double-blind trial of 29,645 participants giving birth vaginally in 10 countries, comparing heat-stable carbetocin with oxytocin for preventing bleeding after birth (2018).7

Limited human data

  • Small, short, or incompletely reported human study Seven studies in septic shock and eight in vasodilatory shock after heart surgery, in which systolic and mean blood pressure rose, summarized in the label without design or size.3
Records collected

27 ClinicalTrials.gov records and 25 PubMed records collected

30 ClinicalTrials.gov records and 30 PubMed records collected

Area of study

Hormones, Brain, nerves and sleep1,8,9

Heart and blood vessels3

Latest dated events
  1. DailyMed publishes the Pitocin label version cited on this page.1
  2. The CHAMPION trial comparing heat-stable carbetocin with oxytocin in 29,645 participants is published.7
  3. FDA approves the Pitocin application cited here, NDA 018261, according to Drugs@FDA.2
  1. DailyMed publishes the Vasostrict label version cited on this page.3
  2. FDA approves Vasostrict, according to Drugs@FDA.4

PeptideScanner reports what the cited sources say. It is not medical advice and does not recommend using, buying or dosing any substance. Read the full disclaimer.

Citations

Sources

Coverage and sources →

Numbered markers in the text point here. Each link opens the original public record.

  1. 1
    PITOCIN (oxytocin) injection · SPL version 15 · published 2026-05-21 ↗

    DailyMed · U.S. National Library of Medicine · Official source · Source checked November 15, 2026

  2. 2
    Drugs@FDA: PITOCIN (oxytocin), NDA 018261 · original approval November 19, 1980 ↗

    U.S. Food and Drug Administration · Official source · Source checked November 15, 2026

  3. 3
    VASOSTRICT (vasopressin) injection · SPL version 49 · published 2026-05-18 ↗

    DailyMed · U.S. National Library of Medicine · Official source · Source checked November 15, 2026

  4. 4
    Drugs@FDA: VASOSTRICT (vasopressin), NDA 204485 · original approval April 17, 2014 ↗

    U.S. Food and Drug Administration · Official source · Source checked November 15, 2026

  5. 5
    HHS Enforcement Discretion Policy Regarding 503A Compounding Using Certain Peptide Bulk Drug Substances, with Appendix A (list of peptides) and Appendix B (identities and justifications) ↗

    U.S. Department of Health and Human Services · Official source · Source checked November 14, 2026

  6. 6
    Enforcement Discretion Policy Regarding 503A Compounding Using Certain Peptide Bulk Drug Substances · notice of availability · 91 FR 68526 · October 30, 2026 ↗

    Federal Register · U.S. Department of Health and Human Services · Official source · Source checked November 14, 2026

  7. 7
    Heat-Stable Carbetocin versus Oxytocin to Prevent Hemorrhage after Vaginal Birth (2018) · PMID 29949473 ↗

    The New England Journal of Medicine · Official source · Source checked November 15, 2026

  8. 8
    ClinicalTrials.gov record NCT02505984 · retained source version 2025-02-25:ba2af36f94b77f220805b39c62fe306d0b89aed52b0abe0465542114e26d499c ↗

    ClinicalTrials.gov · Official source · Source checked November 16, 2026

  9. 9
    ClinicalTrials.gov record NCT02918864 · retained source version 2024-04-05:65c3715794e007eafef745e7e331fc9d327005aeea2e4db502701c5514f4d6fe ↗

    ClinicalTrials.gov · Official source · Source checked November 16, 2026